PT Itama Ranoraya Tbk (IDX:IRRA)
372.00
+2.00 (0.54%)
Sep 2, 2026, 1:30 PM WIB
PT Itama Ranoraya Tbk Revenue
PT Itama Ranoraya Tbk had revenue of 295.10B IDR in the quarter ending June 30, 2026, a decrease of -15.66%. This brings the company's revenue in the last twelve months to 1.05T, down -15.02% year-over-year. In the year 2025, PT Itama Ranoraya Tbk had annual revenue of 1.10T with 12.55% growth.
Revenue (ttm)
1.05T
Revenue Growth
-15.02%
P/S Ratio
0.53
Revenue / Employee
4.52B
Employees
232
Market Cap
557.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.10T | 122.72B | 12.55% |
| Dec 31, 2024 | 977.49B | 281.18B | 40.38% |
| Dec 31, 2023 | 696.30B | -57.27B | -7.60% |
| Dec 31, 2022 | 753.57B | -566.16B | -42.90% |
| Dec 31, 2021 | 1.32T | 755.84B | 134.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Enseval Putera Megatrading Tbk. | 35.18T |
| PT Medela Potentia Tbk | 15.64T |
| PT Soho Global Health Tbk | 10.97T |
| PT Kimia Farma Tbk | 9.56T |
| PT Millennium Pharmacon International Tbk | 4.30T |
| PT Esa Medika Mandiri Tbk | 504.59B |
| PT Diastika Biotekindo Tbk | 205.27B |